Global Myocarditis Disease market size is expected to reach $2.18 billion by 2030 at 6.3%, increasing prevalence of chronic disorders is driving the market growth
Read More
Global Myocardial Ischemia market size is expected to reach $1.14 billion by 2030 at 6.1%, segmented as by symptomatic, acute myocardial ischemia, chronic myocardial ischemia, stable angina, unstable angina
Read More
Global Myocardial Infarction market size is expected to reach $3.15 billion by 2030 at 7.5%, increasing number of smokers propel myocardial infarction market
Read More
Global Myelofibrosis (MF) market size is expected to reach $1.8 billion by 2030 at 3%, rising demand for targeted therapies driving the market growth
Read More
Global Myelodysplastic Syndrome market size is expected to reach $4.65 billion by 2030 at 10.5%, segmented as by myelodysplastic syndrome with unilineage dysplasia, type of dysplasia, patient demographics
Read More
Global Mycosis Fungoides Treatment market size is expected to reach $1.37 billion by 2030 at 5.7%, segmented as by topical steroids, corticosteroid creams or ointments ( hydrocortisone, clobetasol), topical steroid lotions
Read More
The mycoplasma testing market is set to reach $2.1 billion by 2030, growing at 11.1% CAGR, driven by biopharma expansion, PCR testing, and contamination control.
Read More
Global Mycobacterium Tuberculosis market size is expected to reach $4.75 by 2030 at 4.9%, rise in research and development fueling the growth of the market due to increasing demand for innovative treatment solutions
Read More
Global Myasthenia Gravis Treatment market size is expected to reach $2.43 billion by 2030 at 8%, myasthenia gravis treatment market surges in response to escalating disease prevalence
Read More
Global Muscle Wasting Disorders market size is expected to reach $33.5 billion by 2030 at 13.8%, segmented as by medications, anabolic steroids, hormonal treatments, anti-inflammatory drugs, immunomodulatory agents
Read More